This is a routine tax-withholding sale tied to equity vesting, not a discretionary insider sale. No material signal for the stock. Monitor future Form 4 filings for any discretionary insider selling activity.
STIM drugs
STIM drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 10 $2.01entry
- T+1 · 6d ago −19.40%α −20.72% · $1.62
- T+4 · todayOpen
- T+5 · in 9h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Cory Anderson, an officer of Neuronetics, filed a Form 144 notice of intent to sell 5,137 shares of common stock, valued at approximately $10,655, to cover a tax obligation from a vested equity award. The sale is a routine, non-discretionary transaction tied to tax withholding on restricted stock vesting.
Key Facts
- Cory Anderson, an officer, filed Form 144 to sell 5,137 shares of Neuronetics common stock.
- The approximate market value of the proposed sale is $10,654.65.
- The sale is to cover a tax obligation from the settlement of a vested equity award (restricted stock vesting).
- The proposed sale date is November 10, 2026, the same day the filing was accepted.
- The shares are held at Fidelity Brokerage Services LLC.
Financial Impact
Sale of 5,137 shares valued at ~$10,655, representing about 0.06% of the company's $167M market cap.
Risk Factors
- Form 144 is an intent to sell; the actual sale may not occur, but the filing signals the insider considered selling.
- No other insider selling context is provided; this single filing is not indicative of a broader trend.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007913 |
| Document: 0001959173-26-007913-index.html | 0001959173-26-007913 |
| Document: 0001959173-26-007913.txt | 0001959173-26-007913 |
Track record
30 reports on STIM
7 of 12 bullish or bearish reports moved the stock their way by T+1. Best: +11.73% at T+1 after the Nov 10, 2026 report. 8 of 12 went positive at some point.
Filters
- Nov 16, 2026today SC 13D/A Neutral 4/10 Entry price pending
- Nov 16, 2026today SC 13D/A Bearish 6/10 Entry price pending
- Nov 12, 20264d ago 8-K/A Bearish 5/10 Entry $1.39 to $1.25 Now $1.25 +10.07% ▲ +10.07% +8.16% vs SPY
- Nov 12, 20264d ago 8-K Bearish 6/10 Entry $1.43 to $1.39 Now $1.25 +12.59% ▲ +2.80% +2.43% vs SPY
- Nov 12, 20264d ago 424B5 Bearish 6/10 Entry $1.43 to $1.39 Now $1.25 +12.59% ▲ +2.80% +2.43% vs SPY
- Nov 10, 20265d ago Press Release Bearish 6/10 Entry $1.62 to $1.43 Now $1.25 +22.84% ▲ +11.73% +11.37% vs SPY
- Nov 10, 20266d ago 424B5 Bearish 6/10 Entry $1.62 to $1.43 Now $1.25 +22.84% ▲ +11.73% +11.37% vs SPY
- Nov 10, 20266d ago 8-K Neutral 4/10 Entry $1.62 to $1.43 Now $1.25 −22.84% ▼ −11.73% −11.37% vs SPY
- Nov 10, 20266d ago Press Release Bearish 6/10 Entry $1.62 to $1.43 Now $1.25 +22.84% ▲ +11.73% +11.37% vs SPY
- Nov 10, 20266d ago 144 Neutral 2/10 Viewing Entry $2.01 to $1.62 Now $1.25 −37.81% ▼ −19.40% −20.72% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers